EVALUATION OF CHEMICAL COMPONENTS, ANTI-OXIDANT PROPERTIES, AND LETHAL TOXICITY OF ALKALOIDS EXTRACTED FROM ESPAND (Peganum harmala)

Abstract views: 78 / PDF downloads: 248

Authors

  • Fahimi Saeedeh Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
  • Shahrbanoo Oryan Department of Animal Sciences, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran
  • Ramesh Ahmadi Department of Animal Sciences, Faculty of Basic Sciences, Islamic Azad University of Qom
  • Akram Eidi Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran

Keywords:

Peganum harmala, phenolic compounds, high-performance liquid chromatography, antioxidant

Abstract

Peganum harmala L. is a multipurpose medicinal plant frequently used for psychoactive recreational purposes. Harmaline, Harmine, Harmalol, Harmol, and Tetrahydroharmine were determined and quantified as the main b-carboline alkaloids in its extracts. Seeds and roots consisted of the greatest levels of alkaloids, while stems and leaves included low levels of alkaloids. This study aimed to investigate the chemical components, anti-oxidant properties, and lethal toxicity of alkaloids extracted from P. harmala. Accordingly, this plant was collected from Zahedan province (Iran) in spring, and methanolic extract of its seed and leaf was extracted by the Soxhlet method. Then, phytochemical analyses included identifying flavonoids and phenolic compounds, anti-oxidant test, FT-IR analysis, and HPLC analysis. Also, the test was conducted after orally administrating the three doses of the methanolic extract and Harmine to 54 male Wistar rats in three groups (n=6 per group). The results show that, although the anti-oxidant properties of methanolic extract of leaves are higher (because of the existence of flavonoids and phenolic compounds) than seeds, there is a higher amount of β-Carboline in seeds of the plant. The results showed that Harmine was toxic at a much lower dose than the seed extract, and the seed extract can be toxic in low doses than leaf extract.

References

Mikaili, P., Sharifi, M., Shayegh, J., Sarahroodi, S. (2012): Etymological review on chemical and pharmaceutical substances of the oriental origin. International Journal of Animal and Veterinary Advances 4:40-44.

Nenaah, G. (2010): Antibacterial and antifungal activities of (beta)-carboline alkaloids of Peganum harmala (L) seeds and their combination effects. Fitoterapia 81(7):779-782.

Khoushzaban, F., Ghaffarifar, F., Sharafi, M., Ggasemi, N. (2008): Effect of Peganum harmala on acute toxoplasmosis in mice. Daneshvar Med 75(15):27-36.

Movafeghi, A., Abedini, M., Fathiazad, F., Aliasgharpour, M., Omidi, Y. (2009): Floral nectar composition of Peganum harmala L. Natural Product Research 23(3):301-308.

Abdel-Fattah, A.-F.M., Matsumoto, K., Gammaz, H.A.-K., Watanabe, H. (1995): Hypothermic effect of harmala alkaloid in rats: involvement of serotonergic mechanism. Pharmacology Biochemistry Behavior 52(2):421-426.

Grella, B., Dukat, M., Young, R., Teitler, M, Herrick-Davis, K., Gauthier, C.B., Glennon, R.A. (1998): Investigation of hallucinogenic and related β-carbolines. Drug Alcohol Dependence 50(2):99-107.

Farzin, D., Mansouri, N. (2006): Antidepressant-like effect of harmane and other β-carbolines in the mouse forced swim test. European Neuropsychopharmacology 16(5):324-328.

Herraiz, T., González, D., Ancín-Azpilicueta, C., Arán, V.J., Guillén, H. (2010): β-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO). Food Chem Toxicol 48(3):839-845.

Saadabi, A.M. (2006): Antifungal activity of some Saudi plants used in traditional medicine. Asian Journal of Plant Sciences 5:907.

El‐Rifaie, M.E.S. (1980): Peganum harmala: its use in certain dermatoses. International Journal of Dermatology 19(4):221-222.

Monsef, H.R., Ghobadi, A., Iranshahi, M., Abdollahi, M. (2004): Antinociceptive effects of Peganum harmala L. alkaloid extract on mouse formalin test. Journal of Pharmacy and Pharmaceutical Sciences 7(1):65-69.

Shapira, Z., Terkel, J., Egozi, Y., Nyska, A., Friedman, J. (1989): Abortifacient potential for the epigeal parts of Peganum harmala. Journal of Ethnopharmacology 27(3):319-325.

Cepas, J., Silva, M., Pérez-Bendito, D. (1996): Integrated derivatization-chemiluminescence detection system for the determination of β-carboline alkaloids by high-performance liquid chromatography. Journal of Chromatography A 749(1-2):73-80.

Kartal, M., Altun, M., Kurucu, S. (2003): HPLC method for the analysis of harmol, harmalol, harmine and harmaline in the seeds of Peganum harmala L. Journal of Pharmaceutical Biomedical Analysis 31(2):263-269.

Picada, J.N., da Silva, K.V., Erdtmann, B., Henriques, A.T., Henriques, J.A. (1997): Genotoxic effects of structurally related β-carboline alkaloids. Mutation Research/Fundamental Molecular Mechanisms of Mutagenesis 379(2):135-149.

Brkljaca, R., White, J.M., Urban, S. (2015): Phytochemical investigation of the constituents derived from the Australian plant Macropidia fuliginosa. Journal of Natural Products 78(7):1600-1608.

Abderrahman, S.M., Soliman, S., Mohammad, M.G. (2018): Genotoxic effects of Peganum harmala L. in relation to traditional use. J Pharmacogn Phytotherapy 10(9):167-173.

Amadioha, A., Chidi, K.P. (2019): Phytochemical composition of aqueous and ethanolic leaf extracts of Piper guineense, Cassia alata, Tagetes erecta and Ocimum graticimum. Journal of Pharmaceutical Research International:1-8.

Chandrasekar, D., Madhusudhana, K., Ramakrishna, S., Diwan, P.V. (2006): Determination of DPPH free radical scavenging activity by reversed-phase HPLC: a sensitive screening method for polyherbal formulations. Journal of Pharmaceutical Biomedical Analysis 40(2):460-464.

Moloudizargari, M., Mikaili, P., Aghajanshakeri, S., Asghari, M.H., Shayegh, J. (2013): Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids. Pharmacogn Rev 7(14):199-212.

Rezzagui, A., Merghem, M., Derafa, I., Dahamna, S. (2020): Acute and Sub-acute Toxic Effects of Algerian Peganum harmala L. Crud Extract. Journal of Drug Delivery Therapeutics 10(2):115-121.

Mahmoudian, M., Jalipour, H., Salehian Dardashti, P. (2002): Toxicity of Peganum harmala: review and a case report. Iranian Journal of Pharmacology Therapeutics 1(1):1-4.

Pandey, R.K., Shukla, S.S., Tiwari, R., Chauhan, N.S. (2016): Peganam harmala Indian traditional plant: a scientific update. Spatula DD 6(4):103-112.

Edziri, H., Marzouk, B., Mabrouk, H., Garreb, M., Douki, W., Mahjoub, A., Verschaeve, L., Najjar, F., Mastouri, M. (2018): Phytochemical screening, butyrylcholinesterase inhibitory activity and anti-inflammatory effect of some Tunisian medicinal plants. South African Journal of Botany 114:84-88.

Hayet, E., Maha, M., Mata, M., Mighri, Z., Laurent, G., Mahjoub, A. (2010): Biological activities of Peganum harmala leaves. Afr J Biotechnol 9(48):8199-8205.

Benbott, A., Bahri, L., Boubendir, A., Yahia, A. (2013): Study of the chemical components of Peganum harmala and evaluation of acute toxicity of alkaloids extracted in the Wistar albino mice. Journal of Material Environmental Science. p. 558-565.

Downloads

Published

2022-05-29

How to Cite

Saeedeh, F., Oryan, S., Ahmadi, R., & Eidi, A. (2022). EVALUATION OF CHEMICAL COMPONENTS, ANTI-OXIDANT PROPERTIES, AND LETHAL TOXICITY OF ALKALOIDS EXTRACTED FROM ESPAND (Peganum harmala). Journal of Applied Biological Sciences, 16(2), 257–265. Retrieved from https://jabsonline.org/index.php/jabs/article/view/971

Issue

Section

Articles